Trials / Terminated
TerminatedNCT00080028
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Phase I Trial of Motexafin Gadolinium and Chemoradiation in Locally Advanced, Squamous Cell Carcinoma of the Head and Neck
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (planned)
- Sponsor
- Pharmacyclics LLC. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety of adding the investigational drug Motexafin Gadolinium to the standard treatment of radiation therapy and chemotherapy with drugs called 5-FU and cisplatin in patients with advanced head and neck cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Motexafin Gadolinium Injection |
Timeline
- First posted
- 2004-03-23
- Last updated
- 2007-05-08
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00080028. Inclusion in this directory is not an endorsement.